TY - JOUR
AU - D. Abrahami
AU - H. Tesfaye
AU - H. Yin
AU - S. Vine
AU - B. Hicks
AU - O. H. Y. Yu
AU - L. Campeau
AU - R. Platt
AU - S. Schneeweiss
AU - E. Patorno
AU - L. Azoulay
AD - Centre for Clinical Epidemiology, Lady Davis Institute, Jewish General Hospital, Montreal, Quebec, Canada.
Department of Epidemiology, Biostatistics, and Occupational Health, McGill University, Montreal, Quebec, Canada.
Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA.
Centre for Public Health, Queen's University Belfast, Belfast, Northern Ireland, U.K.
Division of Endocrinology, Jewish General Hospital, Montreal, Quebec, Canada.
Department of Urology, Jewish General Hospital, Montreal, Quebec, Canada.
Gerald Bronfman Department of Oncology, McGill University, Montreal, Quebec, Canada.
AN - 36170656
BT - Diabetes Care
DO - 10.2337/dc22-1174
DP - NLM
ET - 2022/09/29
LA - eng
N1 - 1935-5548
Abrahami, Devin
Orcid: 0000-0001-5269-2377
Tesfaye, Helen
Yin, Hui
Vine, Seanna
Hicks, Blánaid
Yu, Oriana H Y
Campeau, Lysanne
Orcid: 0000-0002-0365-4929
Platt, Robert W
Schneeweiss, Sebastian
Patorno, Elisabetta
Orcid: 0000-0002-8809-9898
Azoulay, Laurent
Orcid: 0000-0001-5162-3556
Journal Article
United States
Diabetes Care. 2022 Sep 28:dc221174. doi: 10.2337/dc22-1174.
PY - 2022
SN - 0149-5992
T2 - Diabetes Care
TI - Sodium-Glucose Cotransporter 2 Inhibitors and the Short-term Risk of Bladder Cancer: An International Multisite Cohort Study
ER -